IRIS Accounts Production v24.3.2.46 03747052 Board of Directors 1.5.23 30.4.24 30.4.24 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh037470522023-04-30037470522024-04-30037470522023-05-012024-04-30037470522022-04-30037470522022-05-012023-04-30037470522023-04-3003747052ns15:EnglandWales2023-05-012024-04-3003747052ns14:PoundSterling2023-05-012024-04-3003747052ns10:Director12023-05-012024-04-3003747052ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3003747052ns10:SmallEntities2023-05-012024-04-3003747052ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3003747052ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3003747052ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3003747052ns10:FullAccounts2023-05-012024-04-3003747052ns10:Director22023-05-012024-04-3003747052ns10:RegisteredOffice2023-05-012024-04-3003747052ns5:CurrentFinancialInstruments2024-04-3003747052ns5:CurrentFinancialInstruments2023-04-3003747052ns5:Non-currentFinancialInstruments2024-04-3003747052ns5:Non-currentFinancialInstruments2023-04-3003747052ns5:ShareCapital2024-04-3003747052ns5:ShareCapital2023-04-3003747052ns5:RetainedEarningsAccumulatedLosses2024-04-3003747052ns5:RetainedEarningsAccumulatedLosses2023-04-3003747052ns5:PlantMachinery2023-05-012024-04-3003747052ns5:ComputerEquipment2023-05-012024-04-3003747052ns5:PlantMachinery2023-04-3003747052ns5:MotorVehicles2023-04-3003747052ns5:ComputerEquipment2023-04-3003747052ns5:MotorVehicles2023-05-012024-04-3003747052ns5:PlantMachinery2024-04-3003747052ns5:MotorVehicles2024-04-3003747052ns5:ComputerEquipment2024-04-3003747052ns5:PlantMachinery2023-04-3003747052ns5:MotorVehicles2023-04-3003747052ns5:ComputerEquipment2023-04-3003747052ns5:CostValuation2023-04-3003747052ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3003747052ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30037470521ns10:Director12023-04-30037470521ns10:Director12022-04-30037470521ns10:Director12023-05-012024-04-30037470521ns10:Director12022-05-012023-04-30037470521ns10:Director12024-04-30037470521ns10:Director12023-04-30
REGISTERED NUMBER: 03747052 (England and Wales)















Unaudited Financial Statements For The Year Ended 30th April 2024

for

Vashisht Surgical Limited

Vashisht Surgical Limited (Registered number: 03747052)






Contents of the Financial Statements
For The Year Ended 30th April 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Vashisht Surgical Limited

Company Information
For The Year Ended 30th April 2024







DIRECTORS: Dr R Vashisht
Dr S Vashisht





REGISTERED OFFICE: 1st Floor
5 Century Court
Tolpits Lane
Watford
WD18 9PX





REGISTERED NUMBER: 03747052 (England and Wales)





ACCOUNTANTS: Dua & Co. Limited
1st Floor
5 Century Court
Tolpits Lane
Watford
Hertfordshire
WD18 9PX

Vashisht Surgical Limited (Registered number: 03747052)

Statement of Financial Position
30th April 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 46,529 4,504
Investments 5 48,250 48,250
94,779 52,754

CURRENT ASSETS
Debtors: amounts falling due within one year 6 745,011 1,410,645
Cash at bank 5,694,138 4,789,203
6,439,149 6,199,848
CREDITORS
Amounts falling due within one year 7 381,513 324,109
NET CURRENT ASSETS 6,057,636 5,875,739
TOTAL ASSETS LESS CURRENT LIABILITIES 6,152,415 5,928,493

CREDITORS
Amounts falling due after more than one year 8 33,935 -

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 6,118,478 5,928,491
6,118,480 5,928,493
6,152,415 5,928,493

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit & Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30th January 2025 and were signed on its behalf by:





Dr R Vashisht - Director


Vashisht Surgical Limited (Registered number: 03747052)

Notes to the Financial Statements
For The Year Ended 30th April 2024

1. STATUTORY INFORMATION

Vashisht Surgical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit & Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - 1 ).

Vashisht Surgical Limited (Registered number: 03747052)

Notes to the Financial Statements - continued
For The Year Ended 30th April 2024

4. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1st May 2023 33,119 - 9,325 42,444
Additions - 57,535 - 57,535
At 30th April 2024 33,119 57,535 9,325 99,979
DEPRECIATION
At 1st May 2023 28,849 - 9,091 37,940
Charge for year 1,068 14,384 58 15,510
At 30th April 2024 29,917 14,384 9,149 53,450
NET BOOK VALUE
At 30th April 2024 3,202 43,151 176 46,529
At 30th April 2023 4,270 - 234 4,504

5. FIXED ASSET INVESTMENTS
Investment
£   
COST
At 1st May 2023
and 30th April 2024 48,250
NET BOOK VALUE
At 30th April 2024 48,250
At 30th April 2023 48,250

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 625,161 587,295
Other debtors 2,000 2,000
Loans-WoodLand Hospital 117,850 821,350
745,011 1,410,645

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Hire purchase contracts 5,432 -
Trade creditors 305,517 270,517
Tax 64,321 47,218
Social security and other taxes 85 -
Other creditors - 988
Directors' current accounts 38 256
Accrued expenses 6,120 5,130
381,513 324,109

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Hire purchase contracts 33,935 -

Vashisht Surgical Limited (Registered number: 03747052)

Notes to the Financial Statements - continued
For The Year Ended 30th April 2024

9. RELATED PARTY DISCLOSURE

Fixed asset investment valuation remained the same and relates to joint venture investment.


A commercial loan of £908,350 was given to a third party not controlled by directors and is an unsecured and interest free loan. During the year their were repayments totalling £703,500. The outstanding loan at 30/04/2024 is £117,850 (2023 £821,350).

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30th April 2024 and 30th April 2023:

2024 2023
£    £   
Dr R Vashisht
Balance outstanding at start of year (256 ) (541 )
Amounts advanced 220 285
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (36 ) (256 )

11. ULTIMATE CONTROLLING PARTY

The controlling party is Dr R Vashisht.